Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/28/2012CN101721656B Medicine composition for curing lithiasis and preparation method thereof
03/28/2012CN101698095B Drug composition liniment or lotion for treating white vein diseases and preparation method thereof
03/28/2012CN101691351B Synthesis method of 4-aminopropenylphenyl-1,4-dihydropyridine and medicinal application thereof
03/28/2012CN101690823B Method for preparing RGDV-containing cytosine arabinoside conjugate pharmacosome and application as antitumor agent
03/28/2012CN101676303B Low-molecular-weight glucan, its preparation method and use
03/28/2012CN101646654B Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
03/28/2012CN101597276B Propylidene derivative of N-(Alpha, Beta-dimercapto-Beta-carboxyl propionyl)-amino acid and synthetic method and application thereof
03/28/2012CN101550132B Arylvinylazacycloalkane compounds and methods of preparation and use thereof
03/28/2012CN101550120B Effective component of artemisia leaves and preparation method thereof
03/28/2012CN101534797B Ibuprofen-effervescent preparation having a high dissolution rate and method for the production thereof
03/28/2012CN101528195B Use of hydroxymethyl transferring agent in preparing medicine for treating bone cancer
03/28/2012CN101507726B Association of a sinus If current inhibitor and a beta blocker
03/28/2012CN101502562B Medicament composition for protecting and promoting regeneration function of hepatocyte and preparation method
03/28/2012CN101485652B Composition of taxone compound, and preparation method and application thereof
03/28/2012CN101450047B Use of black mulberry extract as tyrosinase inhibitor
03/28/2012CN101439087B Chinese medicine granule containing salvia root extract and preparation method thereof
03/28/2012CN101439078B Chinese medicine granule containing astragalus extract and preparation method thereof
03/28/2012CN101428012B Medicinal composition for treating cardiovascular and cerebrovascular diseases
03/28/2012CN101411715B Pharmaceutical composition containing acarbose
03/28/2012CN101397270B Polymorphic substance of donepezil salt, preparation and use thereof
03/28/2012CN101395142B 4-amino-1,5-substituted 1,5-dihydro-imidazol-2-ones
03/28/2012CN101291678B Carrier composition for nucleic acid transport
03/28/2012CN101270152B Peptide medicament series for accelerating medulla hematopoiesis cell proliferation
03/28/2012CN101250157B Method for synthesizing 2-substituted-3,4-dihydro-1-isoquinoline ketones and use thereof for preparing cardiovascular agents
03/28/2012CN101218237B Oxime derivative and preparations thereof
03/28/2012CN101189224B Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenyl amino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
03/28/2012CN101160301B Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
03/28/2012CN101139361B Targeting osteoporosis-resistant drug and preparation method thereof
03/28/2012CN101128114B 18-membered macrocycles and analogs thereof
03/28/2012CN101125836B Costene lactone derivative and medical use thereof
03/28/2012CN101121519B Hollow silicon dioxide sub-micron sphere with inner core and its preparation method and use
03/28/2012CN101084178B (benzyloxy-biphenyl) acetic acids and derivatives thereof
03/27/2012USRE43280 Hyperforin derivatives, the use thereof and formulations containing them
03/27/2012US8143486 Delta-5 desaturase and uses thereof
03/27/2012US8143446 Substituted acrylamide derivative and pharmaceutical composition comprising the same
03/27/2012US8143445 HDAC inhibitors
03/27/2012US8143437 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
03/27/2012US8143428 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
03/27/2012US8143425 Heterocyclic aromatic compounds useful as growth hormone secretagogues
03/27/2012US8143424 Thyroid like compounds
03/27/2012US8143422 Benzimidazole derivatives
03/27/2012US8143421 Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/27/2012US8143419 Trisubstituted 1,2,4-triazoles
03/27/2012US8143418 Dimeric small molecule potentiators of apoptosis
03/27/2012US8143414 Hepatitis C virus inhibitors
03/27/2012US8143412 Inhibitors of proliferation and activation of signal transducer and activator of transcription (STATs)
03/27/2012US8143411 Substituted 6-phenylnicotinic acids and their use
03/27/2012US8143410 Kinase inhibitors
03/27/2012US8143404 N-heterocycle urea compounds such as 5-([(butyl{1-[(2-methyl-6-{4-[(methylsulfonyl)amino]phenoxy)-3-pyridinyl)methyl]-4-piperidinyl}amino)carbonyl]amino)-2,4-difluorobenzamide; chemokine receptor CCR5 antagonists for various inflammatory diseases, autoimmune diseases, infectious diseases
03/27/2012US8143393 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/27/2012US8143390 Compositions and methods for inhibiting expression of anti-apoptotic genes
03/27/2012US8143383 Δ-6 desaturase and uses thereof
03/27/2012US8143316 Method for treating peripheral vascular diseases
03/27/2012US8143313 Compositions and methods for preventing or treating an inflammatory response
03/27/2012US8143312 Transparent eye drops containing latanoprost
03/27/2012US8143311 Methods of treating fragile X syndrome and autism
03/27/2012US8143310 Reduction of sterols and other compounds from oils
03/27/2012US8143309 Methods and composition for treating a material
03/27/2012US8143308 Synthesis of oligo/poly(catechins) and methods of use
03/27/2012US8143307 Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same
03/27/2012US8143306 Methods of treating bipolar disorders
03/27/2012US8143305 2,3-substituted indole derivatives for treating viral infections
03/27/2012US8143304 (3-amino-1,2,3,4-tetrahydro-9 H-carbazol-9-yl)-acetic acid derivatives
03/27/2012US8143303 Carbazole derivatives as functional 5-HT6 ligands
03/27/2012US8143302 Methods and compositions for diagnostic and therapeutic targeting of COX-2
03/27/2012US8143301 Hepatitis C virus inhibitors
03/27/2012US8143300 Inhibitors of cellular necrosis
03/27/2012US8143299 Anti-mitotic anti-proliferative compounds
03/27/2012US8143297 Heterocyclic derivatives as modulators of ion channels
03/27/2012US8143296 Thiazole-based compound and inhibitor of T-type calcium channel containing the same
03/27/2012US8143294 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors
03/27/2012US8143293 Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
03/27/2012US8143291 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
03/27/2012US8143290 Chemical compounds 572
03/27/2012US8143289 Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
03/27/2012US8143288 Inhibitors of HCV replication
03/27/2012US8143287 Thrombopoietin mimetics
03/27/2012US8143286 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione)
03/27/2012US8143285 Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
03/27/2012US8143284 Poly(ADP-ribose)polymerase inhibitors
03/27/2012US8143283 Methods for treating blood-born tumors with thalidomide
03/27/2012US8143282 Heterocyclic compounds
03/27/2012US8143281 vasopressin receptor antagonists; indol-3-yl-carbonyl-piperidine-benzopyrrolone, -benzoxazolone and -benzotriazole derivatives; antidepressants, anxiolytic agents; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder
03/27/2012US8143280 Glucocorticoid receptor antagonists
03/27/2012US8143279 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
03/27/2012US8143278 Organic compounds
03/27/2012US8143277 Method of using compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
03/27/2012US8143276 4-thio substituted quinoline and naphthyridine compounds
03/27/2012US8143275 Use of triazolopyrimidine derivatives as microbicides
03/27/2012US8143274 1-(2H)-isoquinolone derivative
03/27/2012US8143273 Quinolizidine and indolizidine derivatives
03/27/2012US8143272 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/27/2012US8143271 Compounds and methods for kinase modulation, and indications therefor
03/27/2012US8143270 2-amino 1H-in-imidazo ring systems and methods
03/27/2012US8143269 Inhibitors of store operated calcium release
03/27/2012US8143268 Bicyclic pyrimidinones and uses thereof
03/27/2012US8143267 Dosing interval of the nimesulide overlaps with that of the oxycodone to reduce the amount of oxycodone needed to provide an effect
03/27/2012US8143266 Aryl heterocyclic CGRP receptor antagonists
03/27/2012US8143265 Administering 2-aminopurine or a pharmaceutically salt thereof; optionally also administering an additional hypolipidemic agent; 2-AP and nonphosphorylatable eIF-2 alpha mutant inhibit eIF-2 alpha phosphorylation, inhibit foam cell formation and atherosclerosis development
03/27/2012US8143264 Xanthine derivatives as selective HM74A agonists
1 ... 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 ... 7860